Helen Tager-Flusberg is director of the Center for Autism Research Excellence at Boston University. Her research aims to untangle autism and language impairments using behavioral and brain-imagining studies. She was also a columnist for Spectrum.
Boston University
Helen Tager-Flusberg is director of the Center for Autism Research Excellence at Boston University. Her research aims to untangle autism and language impairments using behavioral and brain-imagining studies. She was also a columnist for Spectrum.
A diagnosis of social communication disorder only keeps people from a community and resources they desperately want and need.
Studying parents of children with autism has long been controversial, but that doesn’t mean scientists should avoid it.
Elsa, the star of the movie “Frozen,” is the poster child for girls with autism.
Scientists should slow down and return to the basic tenets of research to regain the public’s trust.
Trials to test drugs for autism suffer from subjective measurements and placebo effects. Helen Tager-Flusberg outlines how to ferret out the true effects of potential autism therapies.
Complex, multidimensional tasks that unfold over time could reveal how different brain areas work together to support decisions.
Complex, multidimensional tasks that unfold over time could reveal how different brain areas work together to support decisions.
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.